ProPublica’s investigation reveals that over a dozen Trump administration officials, including Attorney General Pam Bondi, strategically divested themselves of substantial stock holdings shortly before President Trump’s “Liberation Day” tariffs negatively impacted the market. These preemptive sales, totaling millions of dollars, occurred within days of the market downturn, with some officials repurchasing shares at reduced prices afterward. Examples include a State Department official’s $50,000 sale and Transportation Secretary Sean Duffy’s sale of shares in nearly 36 companies. This pattern raises concerns about potential insider trading.
Read More
Attorney General Pam Bondi sold between $1 million and $5 million in Trump Media & Technology Group shares on April 2nd, the same day President Trump announced sweeping tariffs. This occurred on “Liberation Day,” when tariffs caused market drops, followed by a 90-day pause. While there is no suggestion of wrongdoing, the timing of the sale, falling within Bondi’s 90-day window to divest from Trump Media per her ethics agreement, and subsequent stock price fluctuations warrant attention. Bondi’s actions are subject to scrutiny, alongside other aspects of her career, including her past lobbying work for Qatar.
Read More
Attorney General Pam Bondi sold between $1 million and $5 million in Trump Media shares on April 2nd, the same day President Trump announced new tariffs that caused a market downturn. Bondi’s disclosure forms don’t specify the exact time of sale, but the transactions occurred before or after the market closed following Trump’s press conference. While the legality of the sale is unclear, it raises questions regarding potential insider trading, given Bondi’s prior work with Trump Media. The Justice Department has yet to comment.
Read More
UnitedHealth chair and executives offloaded a staggering $102 million worth of company stock just before the Department of Justice (DOJ) probe became public knowledge. This timing has understandably raised significant eyebrows, prompting questions about the nature of these transactions and the potential for insider trading. The sheer scale of the sales alone is enough to warrant a closer look.
The initial reaction suggests a strong suspicion of wrongdoing, fueled by the well-known prevalence of such practices in corporate America. The assumption that regulatory bodies, like the Securities and Exchange Commission (SEC), are unlikely to take decisive action against powerful figures only reinforces this cynicism.… Continue reading
John Q. Hosedrinker 
Matt Underwood